Brief: Monopar And Northstar Amend & Extend Collaboration
11/06/2024 13:04
June 11 (Reuters) - Monopar Therapeutics Inc MNPR.O :
* MONOPAR AND NORTHSTAR AMEND & EXTEND COLLABORATION
* MONOPAR THERAPEUTICS: CO AND NORTHSTAR GOT INTO LONG-TERM,
NON-EXCLUSIVE MASTER SUPPLY AGREEMENT
* MONOPAR THERAPEUTICS: AGREEMENT FOR NORTHSTAR TO PROVIDE
CO WITH
POWERFUL THERAPEUTIC RADIOISOTOPE ACTINIUM-225 (AC-225)
* MONOPAR THERAPEUTICS INC: BOTH COMPANIES WILL SHARE
OWNERSHIP OF
FILED PATENT APPLICATION ON USE OF PCTA AS A LINKER WITH AC-225
Source text for Eikon: ID:nGNX8S6twF
Further company coverage: MNPR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Monopar Therapeutics
See all newsBrief: Monopar Appoints Jeffrey D. Kent, M.D., As Executive Vice President, Head Of Medical Affairs Announces Two Alxn1840 Presentations At Aasld – The Liver Meeting 2026
U.S. RESEARCH ROUNDUP-Airbnb, Five Below, Silgan Holdings
Monopar Therapeutics Inc. reports results for the quarter ended June 30 - Earnings Summary
Monopar Therapeutics Inc. expected to post a loss of 62 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP-Alphabet, IBM, Tesla